IP Library Patent Application 62715351
Patent Application Provisional Small
App. No. 62/715,351 · Confirmation No. 5050

ANTI-EGF ANTIBODIES AND THEIR THERAPEUTIC SYNERGISTIC EFFECT ON ALK AND MEK INHIBITORS

Applicant: In3Bio Ltd.
Provisional Application Expired
⬇ PDF
Code Description Pages PDF
2026-02-04 OATH Oath or Declaration filed 42 View
2026-02-04 OATH Oath or Declaration filed 42 View
2021-01-08 APP.FILE.REC Filing Receipt 3 View
2019-12-05 PD.AUTH.G Acceptance of Permission to Access Application 1 View
2019-12-05 APP.FILE.REC Filing Receipt 3 View
2019-12-05 M327 Miscellaneous Communication to Applicant - No Action Count 1 View
2019-12-03 PD.TO.AUTH Authorization or Rescission of Authorization to Access Application by Digital Access Service /Priority Document Exchange Office 2 View
2019-12-03 N417 Electronic Filing System Acknowledgment Receipt 2 View
2019-11-01 R46C.REQ Request under 37CFR1.46(c) to correct, update, change applicant 2 View
2019-11-01 ADS Application Data Sheet 8 View
2019-11-01 WFEE Fee Worksheet (SB06) 2 View
2019-11-01 N417 Electronic Filing System Acknowledgment Receipt 2 View
2019-08-16 R46C.REQ Request under 37CFR1.46(c) to correct, update, change applicant 2 View
2019-08-16 ADS Application Data Sheet 8 View
2019-08-16 N417 Electronic Filing System Acknowledgment Receipt 2 View
2018-08-13 APP.FILE.REC Filing Receipt 3 View
2018-08-07 ADS Application Data Sheet 7 View
2018-08-07 SPEC Specification 17 View
2018-08-07 APPENDIX Appendix to the specification 1 View
2018-08-07 WFEE Fee Worksheet (SB06) 2 View
2018-08-07 N417 Electronic Filing System Acknowledgment Receipt 3 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
62/715,351
Filed
2018-08-07